Τόμος 23 (2009) – Τεύχος 3 – Άρθρο 6 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 23 (2009) – Issue 3 – Article 6 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Division of Aesthetics and Cosmetology, School of Health and Caring Professions, Technological Educational Institution of Athens, Athens, Hellas

pharmakonpress[at]pharmakonpress[.]gr

2. Nott M.R.: Correspondence: EMLA or Ametop, and for how long? Anaesthesia 56: 1026-1027 (2001)

3. Godwin Y., Brotherston M.: Hyperpigmentation following the use of Emla cream. Br. J. Plast. Surg. 54: 82-83 (2001)

4. McMillan A., Walshaw D., Meechan J.: The efficacy of Emla® and 5% lignocaine gel for anaesthesia of human gingival mucosa. Br. J. Oral Maxillofacial Surg. 38: 58-61 (2000)

5. Serour F., Ben-Yehuda Y., Boaz M.: EMLA® cream prior to digital nerve block for ingrown nail surgery does not reduce pain at injection of anesthetic solution. Acta Anaesth. Scand. 46: 203-206 (2002)

6. Egekvist H., Bjerring P.: Effect of EMLA Cream on skin thickness and subcutaneous venous diameter. A Randomized, Placebo-controlled study in children. Acta Dermato-Vener. 80: 340-343 (2000)

7. Neri I., Savoia F., Guareschi E.: Purpura after application of EMLA cream in two children. Pediatr. Dermatol. 22: 566-568 (2005)

8. Browne I., Fung M., Donelly M.: The use of EMLA reduces the pain associated with digital ring block for ingrowing toenail correction. Eur. J. Anaesth. 17: 182-184 (2000)

9. Browne J., Raza A., Awad I.: The effects of EMLA and topical formulation of 4% amethocaine on pain associated with retrobulbar injection. Anesthesia 54: 596-598 (1999)

10. Yosipovitch G., Maibach H., Rowbotham M.: Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia. Acta Dermato-Vener. 79: 118-121(1999)

11. Koppel A., Coleman M., Coleman P.: The Efficacy of EMLA versus ELA-Max for pain relief in medium-depth chemical peeling: A Clinical and histopathologic evaluation. Dermatol. Surg. 26: 61-64 (2000)

12. Dohlwitz A., Hellnkerg B., Svedmyr R.: No negative influence of EMLA application prior to BCG vaccination. Acta Paediatr. 87: 480-483 (1998)

13. Waton J., Boulanger A., Trechot P.: Contact urticarial from Emla® cream. Cont. Derm. 52(2): 111-114 (2005)

14. Ismail F., Goldsmith P.C.: Emla® cream induced allergic contact dermatitis in a child with thalassaemia. Cont. Derm. 52: 111-114 (2005)

15. Mintegi S., Benito J., Astobiza E.: CORRESPONDENCE: Methemoglobinemia and CNS toxicity after topical application of EMLA to a 4-year old girl with Molluscum Contagiosum. Pediatr. Dermatol. 23: 592-593 (2006)

16. Koh L., Harrison D.: A randomized, double-blind comparison study of EMLA® and ELA-Max® for topical anesthesia in children undergoing intravenous insertion. Paediatr. Anaesth. 14: 977-982 (2004)

17. Dong H., Keri H., Cerroni L.: EMLA® cream-indused irritant contact dermatitis. J. Cutan. Pathol. 29: 190-192 (2002)

18. Kuwahara T., Skinner B.: EMLA versus ice as a topical anesthetic. Dermatol. Surg. 27: 495-496 (2001)

19. Kefala V., Protopapa E., Plessas S.: Photoaging: An esthetic problem.prevention or treatment? Rev. Clin. Pharmacol. Pharmacokinet. 15: 33-42 (2001)

20. Kefala V., Plessas S.: Topical and systemic therapeutic management of acne. Rev. Clin. Pharmacol. Pharmacokinet. 14: 101-110 (2000)

21. Kefala V., Protopapa E., Plessas S.: The use of chemical peeling in the management of esthetic problems deriving from skin diseases. Rev. Clin. Pharmacol. Pharmacokinet. 15: 5-14 (2001)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr